Listed

Sunshine Biopharma Inc.: Form 10-Q for the period ended Sep 30, 2011

Filed with the SEC on Nov 8, 2011 and accepted by EDGAR at Nov 8, 2011, 13:50 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-07-01 to 2011-09-30$0us-gaap:SalesRevenueGoodsNet
Revenue9 months2011-01-01 to 2011-09-30$0us-gaap:SalesRevenueGoodsNet
Research and development3 months2011-07-01 to 2011-09-30$0us-gaap:ResearchAndDevelopmentExpense
Research and development9 months2011-01-01 to 2011-09-30$17.6kus-gaap:ResearchAndDevelopmentExpense
Net income3 months2011-07-01 to 2011-09-30−$116.4kus-gaap:NetIncomeLoss
Net income9 months2011-01-01 to 2011-09-30−$184.1kus-gaap:NetIncomeLoss
Basic EPS3 months2011-07-01 to 2011-09-30$0.00us-gaap:EarningsPerShareBasic
Basic EPS9 months2011-01-01 to 2011-09-30−$0.01us-gaap:EarningsPerShareBasic
Operating cash flow9 months2011-01-01 to 2011-09-30−$179.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2011-09-30$178.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-09-30$224.2kus-gaap:AssetsCurrent
Total assetsAt period end2011-09-30$224.2kus-gaap:Assets
Total liabilitiesAt period end2011-09-30$4.5kus-gaap:Liabilities
Shareholders' equityAt period end2011-09-30$219.7kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-11-004118. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.